Publicaciones en colaboración con investigadores/as de John Radcliffe Hospital (8)

2013

  1. Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression

    British Journal of Haematology, Vol. 163, Núm. 2, pp. 235-239

  2. Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells

    British Journal of Haematology, Vol. 160, Núm. 6, pp. 842-850

  3. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes

    Haematologica, Vol. 98, Núm. 12, pp. 1856-1864

2012

  1. Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics

    PLoS ONE, Vol. 7, Núm. 8

  2. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia

    PLoS ONE, Vol. 7, Núm. 2

2010

  1. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

    Leukemia

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051

  2. Novel translocations that disrupt the platelet-derived growth factor receptor β (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders

    British Journal of Haematology, Vol. 120, Núm. 2, pp. 251-256